Sponsor:
Optos, PLC
Code:
NCT02921568
Conditions
Retinal Disease
Glaucoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
P200TE
Spectral OCT/SLO
Brief summary:
Conditions
Retinal Disease
Glaucoma
Study ID
NCT02921568
Start date
Sep, 2016
Status verified date
Sep, 2016
Primary completion date
Dec, 2017
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Intervention Model
Single group
Primary purpose
Other
Arms
other: All patients
Interventions
P200TE
Spectral OCT/SLO
Primary outcome measure
Locations
Medical Center Ophthalmology Associates
Recruiting
San Antonio, Texas, United States, 78240
Contacts
Principal Investigator:
Michael Singer, MD
Sponsor
Optos, PLC
Last update posted
Mar 14, 2017
Last verified
Sep, 2016
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Optos, PLC on 2017-03-14.